Clinical Trial Update: Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for nelonemdaz aiming to reduce reperfusion injury in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• nelonemdaz (nelonemdaz)

Snippet

Sponsor: GNT Pharma | Conditions: Ischemic Stroke | Phase 3 | Status: UNKNOWN